<DOC>
	<DOCNO>NCT02963155</DOCNO>
	<brief_summary>Prospective research Natural Killer cell predictive biomarkers stratify patient likely longer response time castration .</brief_summary>
	<brief_title>Study Natural Killer Cells Patients With Metastatic Prostate Cancer : Relationship With Survival Response Time Castration</brief_title>
	<detailed_description>The main objective validate prospectively result retrospective study show correlation level NKp30 NKp46 receptor-activators expression surface NK cell 1 ) survival time , 2 ) response time castration patient metastatic prostate cancer . Prospective monocenter , open-label study . During visit frame management disease , single blood sample collect . Patients standard care follow-up period 5 year . Follow data ( death , progression ) collect every 6 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Patient metastatic prostate cancer . 2 . Aged 18 year . 3 . Patient period sensitivity castration ( patient non castrate castration perform less 1 year ago ) lack progression . 4 . Patient sign informed consent . 5 . Patient affiliate national `` Social Security '' regimen beneficiary regimen . 1 . Patient chemotherapy treatment time sample 2 . Patient corticotherapy treatment time sample 3 . Patient emergency situation , adult subject measure legal protection ( place judicial protection , tutorship , curatorship ) , unable give consent . 4 . Any psychological , familial , sociological geographical condition potentially hamper compliance study medical followup 5 . Contraindications study procedure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>prostate , metastatic</keyword>
</DOC>